Additionally, our findings indicated that CD8+ T cells, resting mast cells, plasma cells, resting dendritic cells and Tregs were all significantly associated with a favorable OS in patients with NSCLC (Figures 6C–G). The gene discussed is CD8A; the disease is non-small cell lung carcinoma.